Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family-Reference-Cited by-同舟云学术

Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family

Published:2017-05 Issue:9 Volume:25 Page:2657-2665
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Bataille Carole J.R.,Brennan Méabh B.,Byrne Simon,Davies Stephen G.,Durbin Matthew,Fedorov Oleg,Huber Kilian V.M.,Jones Alan M.,Knapp Stefan,Liu Gu,Nadali Anna,Quevedo Camilo E.,Russell Angela J.,Walker Roderick G.,Westwood Robert,Wynne Graham M.

Funder

Cancer Research UK

Research Councils United Kingdom

SGC

AbbVie

Bayer Pharma AG

Boehringer Ingelheim

Canada Foundation for Innovation

Eshelman Institute for Innovation

Genome Canada

Innovative Medicines Initiative

Janssen, Merck & Co.

Novartis Pharma AG

Ontario Ministry of Economic Development and Innovation

Pfizer

São Paulo Research Foundation

Takeda

Wellcome Trust

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference74 articles.

1. Protein kinases and phosphatases in the control of cell fate;Bononi;Enzyme Res,2011

2. The structural basis for control of eukaryotic protein kinases;Endicott;Annu Rev Biochem,2012

3. The protein kinase complement of the human genome;Manning;Science (Washington, DC, U S),2002

4. Targeting protein serine/threonine phosphatases for drug development;McConnell;Mol Pharmacol,2009

5. Protein kinases – the major drug targets of the twenty-first century?;Cohen;Nat Rev Drug Discov,2002

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure–Activity Relationship Study and Design Strategies of Hydantoin, Thiazolidinedione, and Rhodanine-Based Kinase Inhibitors: A Two-Decade Review;ACS Omega;2024-01-19

2. Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) kinase inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

3. New 3-aminorhodanine derivatives: Synthesis, characterization, docking study and biological activates;F1000Research;2023-10-18

4. Synthesis of 5-arylidenerhodanines in L-proline-based deep eutectic solvent;Beilstein Journal of Organic Chemistry;2023-10-04

5. Synthesis and in vitro anticancer potential of new thiazole-containing derivatives of rhodanine;Chemistry of Heterocyclic Compounds;2023-07